SavedAdd your journal

Journals / Journal of Ankara Medical School / 1999 / Cilt: 21 - Sayı: 2

Prostatitis and prostate-specific antigen

Lütfü TAHMAZ
Orhan YALÇIN
Murat DAYANÇ
Mete KİLCİLER
A. Fuat PEKER
Doğan ERDURAN
Pages
77–80
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: When PSA is referred to as a tumor marker, it should be noted that coexisting prostate inflammation may contribute to a rise in PSA levels without any malignancy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study is to investigate the possible effects of prostatitis on prostate-specific antigen (PSA) concentration.
📊
Key Findings & Data:Materials and Methods: PSA levels were measured in 54 selected patients with prostatic infection and no incidence of benign prostatic hyperplasia (BPH) and prostatic cancer.
💡
Conclusion & Impact:Conclusion: When PSA is referred to as a tumor marker, it should be noted that coexisting prostate inflammation may contribute to a rise in PSA levels without any malignancy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study is to investigate the possible effects of prostatitis on prostate-specific antigen (PSA) concentration. Materials and Methods: PSA levels were measured in 54 selected patients with prostatic infection and no incidence of benign prostatic hyperplasia (BPH) and prostatic cancer. Results: PSA levels were found to increase (over 4 ng/ml) in 4 of 5 (80%) patients with acute prostatitis, in 4 of 19 (21%) patients with chronic-bacterial prostatitis and in 3 of 20 (%15) patients with abacterial prostatitis. PSA levels returned to normal by antibiotherapy in 8 patients with acute and chronic bacterial prostatitis and 3 patients with chlamydia infection. Conclusion: When PSA is referred to as a tumor marker, it should be noted that coexisting prostate inflammation may contribute to a rise in PSA levels without any malignancy

🔖

Cite This Article

TAHMAZ, L., YALÇIN, O., DAYANÇ, M., KİLCİLER, M., PEKER, A. F., ERDURAN, D. (2022). Prostatitis and prostate-specific antigen. Journal of Ankara Medical School, Cilt: 21 - Sayı: 2, 77–80. https://ajindex.com/articles/560067

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...